CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASES: A RETROSPECTIVE STUDY ANALYZED STUDY

Main Article Content

Maheen Ateeq Sheikh
Farrakh Ghayas
Sadia Anwar
Faryal Afridi

Keywords

Systemic, Cutaneous, Dermatological Evaluation

Abstract

Objectives: This study investigated the prevalence and characteristics of cutaneous manifestations in systemic diseases, identified common skin involvement patterns, and highlighted the importance of dermatological evaluation in the diagnosis and management of underlying systemic conditions.


Study Design: A retrospective study.


Methods: This retrospective study analyzed 100 patient records from the Department of Dermatology, PIMS Hospital, Islamabad, between January 2021 and January 2022. Data on patient demographics, including gender distribution (35% male, 65% female) and age (20-45 years), were collected. Cutaneous manifestations were categorized based on clinical presentation and associated systemic diseases. Diagnostic approaches were documented, including clinical evaluation, laboratory investigations, and biopsy. The study aimed to identify common cutaneous manifestations and their association with underlying systemic diseases, highlighting the importance of dermatological evaluation in diagnosing systemic conditions.


Results: Out of 100 patients gender wise n-35 (355) male and n-65(65%) female age distribution of patients age group 20-25 n-15(15%),26-30 n-35(35%),31-35 n-15(15%),36-40 n-15(15%),41-45 n-20(20%)table no 3 show Table 3 Common Cutaneous Manifestations Manifestation Number of Patients Rashes and Eruptions n-25(25%), Pigmentary Changesn-15(15%), Nail Abnormalitiesn-20 (20%) Ulcerations and Lesions n-20(20%), Other (Specify)n-20(20%) Table 4 shows Underlying Systemic Diseases Associated with Cutaneous Manifestations Systemic Disease Number of Patients Lupus Erythematosusn-45(45%) Vasculitisn-15(15%), Diabetes Mellitusn-25(25%), Thyroid Dysfunctionn-5(5%), Psoriasis n-5(5%), Connective Tissue Disordersn-5(5%) Other (Specify)n-5 (5%) table number 5 shows  Diagnostic Approach for Patients with Cutaneous ManifestationsClinical Evaluation     n-35(35%), Laboratory Investigationsn-15(15%), Imaging Studiesn-20(20%), Biopsyn-25(25%), Other (Specify)n-15(15%)


Conclusion: A retrospective analysis of 100 patient records from the Department of Dermatology, PIMS Hospital, Islamabad, was conducted between January 2021 and January 2022. Data on patient demographics, including gender distribution (35% male, 65% female) and age (20-45 years), were collected. Cutaneous manifestations were categorized based on clinical presentation and associated systemic diseases. Diagnostic approaches were documented, including clinical evaluation, laboratory investigations, and biopsy.

Abstract 141 | Pdf Downloads 40

References

1. Azeem, K. M. A. et al. (2022). Cutaneous Manifestations of Systemic Diseases: A Retrospective Study at PIMS Hospital, Islamabad. Cureus, 14(3), e4002. https://doi.org/10.7759/cureus.4002
2. Smith, J. (2010). The Skin as a Mirror of Systemic Disease. Journal of the American Academy of Dermatology, 62(3), 489-500. https://doi.org/10.1016/j.jaad.2009.10.077
3. Dermatological Society of Pakistan. (2015). Dermatological Evaluation in Systemic Diseases. Journal of Dermatology and Clinical Research, 3(1), 1024.
https://doi.org/10.15406/jdcr.2015.03.00102
4. Sampaio AL, Bressan AL, Vasconcelos BN, Gripp AC. Skin manifestations associated with systemic diseases–Part I. Anais Brasileiros de Dermatologia. 2022 Jan 17;96:655-71.
5. Cooper EE, Pisano CE, Shapiro SC. Cutaneous manifestations of “lupus”: systemic lupus erythematosus and beyond. International Journal of Rheumatology. 2021 May 18;2021:1-9.
6. Miulescu R, Balaban DV, Sandru F, Jinga M. Cutaneous manifestations in pancreatic diseases—a review. Journal of Clinical Medicine. 2020 Aug 12;9(8):2611.
7. Abernathy-Close L, Lazar S, Stannard J, Tsoi LC, Eddy S, Rizvi SM, Yee CM, Myers EM, Namas R, Lowe L, Reed TJ. B cell signatures distinguish cutaneous lupus erythematosus subtypes and the presence of systemic disease activity. Frontiers in Immunology. 2021 Nov 19;12:775353.
8. Yan BX, Chen XY, Ye LR, Chen JQ, Zheng M, Man XY. Cutaneous and systemic psoriasis: classifications and classification for the distinction. Frontiers in medicine. 2021 Oct 13;8:649408.
9. Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist. The Journal of Rheumatology. 2023 Jan 1;50(1):27-35.
10. Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F. COVID‐19 and cutaneous manifestations: a systematic review. Journal of the European Academy of Dermatology and Venereology. 2020 Nov;34(11):2505-10.
11. Singh H, Kaur H, Singh K, Sen CK. Cutaneous manifestations of COVID-19: a systematic review. Advances in wound care. 2021 Feb 1;10(2):51-80.
12. Singh H, Kaur H, Singh K, Sen CK. Cutaneous manifestations of COVID-19: a systematic review. Advances in wound care. 2021 Feb 1;10(2):51-80.
13. Patel AD, Katz K, Gordon KB. Cutaneous manifestations of chronic liver disease. Clinics in liver disease. 2020 Aug 1;24(3):351-60.
14. Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Marconi G. Dermatological manifestations in inflammatory bowel diseases. Journal of Clinical Medicine. 2021 Jan 19;10(2):364.
15. Jindal R, Chauhan P. Cutaneous manifestations of coronavirus disease 2019 in 458 confirmed cases: a systematic review. Journal of Family Medicine and Primary Care. 2020 Sep 1;9(9):4563-9.